These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

296 related items for PubMed ID: 19853479

  • 1. The efficacy of photopheresis for bronchiolitis obliterans syndrome after lung transplantation.
    Morrell MR, Despotis GJ, Lublin DM, Patterson GA, Trulock EP, Hachem RR.
    J Heart Lung Transplant; 2010 Apr; 29(4):424-31. PubMed ID: 19853479
    [Abstract] [Full Text] [Related]

  • 2. Extracorporeal photopheresis after lung transplantation: a 10-year single-center experience.
    Benden C, Speich R, Hofbauer GF, Irani S, Eich-Wanger C, Russi EW, Weder W, Boehler A.
    Transplantation; 2008 Dec 15; 86(11):1625-7. PubMed ID: 19077900
    [Abstract] [Full Text] [Related]

  • 3. Factors Associated With Mortality and Response to Extracorporeal Photopheresis in Lung Allograft Recipients With Bronchiolitis Obliterans Syndrome.
    Karnes HE, Schindler EI, Morrell M, Hachem RR, Berman K, Vedantham S, Atkinson J, Spitznagel E, Despotis GJ.
    Transplantation; 2019 May 15; 103(5):1036-1042. PubMed ID: 30130331
    [Abstract] [Full Text] [Related]

  • 4. A prospective interventional study on the use of extracorporeal photopheresis in patients with bronchiolitis obliterans syndrome after lung transplantation.
    Jaksch P, Scheed A, Keplinger M, Ernst MB, Dani T, Just U, Nahavandi H, Klepetko W, Knobler R.
    J Heart Lung Transplant; 2012 Sep 15; 31(9):950-7. PubMed ID: 22884382
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of Extracorporeal Photopheresis in Patients With Bronchiolitis Obliterans Syndrome After Lung Transplantation.
    Pecoraro Y, Carillo C, Diso D, Mantovani S, Cimino G, De Giacomo T, Troiani P, Shafii M, Gherzi L, Amore D, Rendina EA, Venuta F, Anile M.
    Transplant Proc; 2017 May 15; 49(4):695-698. PubMed ID: 28457374
    [Abstract] [Full Text] [Related]

  • 6. Extracorporeal Photopheresis for Bronchiolitis Obliterans Syndrome After Lung Transplantation.
    Hachem R, Corris P.
    Transplantation; 2018 Jul 15; 102(7):1059-1065. PubMed ID: 29557913
    [Abstract] [Full Text] [Related]

  • 7. Therapy options for chronic lung allograft dysfunction-bronchiolitis obliterans syndrome following first-line immunosuppressive strategies: A systematic review.
    Benden C, Haughton M, Leonard S, Huber LC.
    J Heart Lung Transplant; 2017 Sep 15; 36(9):921-933. PubMed ID: 28662986
    [Abstract] [Full Text] [Related]

  • 8. Lung transplant recipients on long-term extracorporeal photopheresis.
    Isenring B, Robinson C, Buergi U, Schuurmans MM, Kohler M, Huber LC, Benden C.
    Clin Transplant; 2017 Oct 15; 31(10):. PubMed ID: 28653398
    [Abstract] [Full Text] [Related]

  • 9. The efficacy of extracorporeal photopheresis to arrest bronchiolitis obliterans in lung allograft recipients was compared between two automated photopheresis instruments.
    Chionis L, Grossman BJ, Hachem R, Commean P, Derfler MC, Vedantham S, Dodds K, Spitznagel E, Atkinson J, Despotis G.
    Transfusion; 2018 Dec 15; 58(12):2933-2941. PubMed ID: 30312482
    [Abstract] [Full Text] [Related]

  • 10. Initiation of extracorporeal photopheresis in lung transplant patients with mild to moderate refractory BOS: A single-center real-life experience.
    Leroux J, Hirschi S, Essaydi A, Bohbot A, Degot T, Schuller A, Olland A, Kessler R, Renaud-Picard B.
    Respir Med Res; 2022 May 15; 81():100913. PubMed ID: 35525096
    [Abstract] [Full Text] [Related]

  • 11. Extracorporeal photopheresis to attenuate decline in lung function due to refractory obstructive allograft dysfunction.
    EPI Study Group, Hage CA, Klesney-Tait J, Wille K, Arcasoy S, Yung G, Hertz M, Chan KM, Morrell M, Goldberg H, Vedantham S, Derfler MC, Commean P, Berman K, Spitznagel E, Atkinson J, Despotis G.
    Transfus Med; 2021 Aug 15; 31(4):292-302. PubMed ID: 33955079
    [Abstract] [Full Text] [Related]

  • 12. Cessation of extracorporeal photopheresis in chronic lung allograft dysfunction: effects on clinical outcome in adults.
    Robinson CA, Huber L, Murer C, Schuurmans M, Kohler M, Hofbauer G, Benden C.
    Swiss Med Wkly; 2017 Aug 15; 147():w14429. PubMed ID: 28488260
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of extracorporeal photopheresis on lung function decline for severe bronchiolitis obliterans syndrome following allogeneic stem cell transplantation.
    Brownback KR, Simpson SQ, Pitts LR, Polineni D, McGuirk JP, Ganguly S, Aljitawi OS, Lin TL, Singh A, Abhyankar S.
    J Clin Apher; 2016 Aug 15; 31(4):347-52. PubMed ID: 26031713
    [Abstract] [Full Text] [Related]

  • 16. Long-Term Off-Line Extracorporeal Photochemotherapy in Patients with Chronic Lung Allograft Rejection Not Responsive to Conventional Treatment: A 10-Year Single-Centre Analysis.
    Del Fante C, Scudeller L, Oggionni T, Viarengo G, Cemmi F, Morosini M, Cascina A, Meloni F, Perotti C.
    Respiration; 2015 Aug 15; 90(2):118-28. PubMed ID: 26112178
    [Abstract] [Full Text] [Related]

  • 17. Are we near to an effective drug treatment for bronchiolitis obliterans?
    Verleden GM, Vos R, Dupont L, Van Raemdonck DE, Vanaudenaerde BM, Verleden SE.
    Expert Opin Pharmacother; 2014 Oct 15; 15(15):2117-20. PubMed ID: 25154562
    [Abstract] [Full Text] [Related]

  • 18. Bronchiolitis obliterans syndrome and restrictive allograft syndrome: do risk factors differ?
    Verleden SE, Ruttens D, Vandermeulen E, Vaneylen A, Dupont LJ, Van Raemdonck DE, Verleden GM, Vanaudenaerde BM, Vos R.
    Transplantation; 2013 May 15; 95(9):1167-72. PubMed ID: 23425818
    [Abstract] [Full Text] [Related]

  • 19. Long-term azithromycin for bronchiolitis obliterans syndrome after lung transplantation.
    Gottlieb J, Szangolies J, Koehnlein T, Golpon H, Simon A, Welte T.
    Transplantation; 2008 Jan 15; 85(1):36-41. PubMed ID: 18192909
    [Abstract] [Full Text] [Related]

  • 20. Phenotyping established chronic lung allograft dysfunction predicts extracorporeal photopheresis response in lung transplant patients.
    Greer M, Dierich M, De Wall C, Suhling H, Rademacher J, Welte T, Haverich A, Warnecke G, Ivanyi P, Buchholz S, Gottlieb J, Fuehner T.
    Am J Transplant; 2013 Apr 15; 13(4):911-918. PubMed ID: 23406373
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.